chiang rai launches

Chiang Rai Launches New Health Initiative to Combat Chronic Kidney Disease

ByJustpaste.in

CHIANG RAI – On July 10, 2026, Chiang Rai took a major step toward better community health. The city officially launched the “Reduce Kidney Failure Risk, Extend Quality of Life” project. Acting Sub-Lieutenant Bunrit Ayuyuen, the Deputy Municipal Clerk, opened the event at the Mueang Chiang Rai District Public Health Office.

The new program specifically targets at-risk residents and members of local public health networks. It aims to build a solid understanding of chronic kidney disease prevention across the community. Furthermore, health officials want to actively promote correct, everyday health care habits among all locals.

Key Takeaways:

  • Chiang Rai officially launched a focused health project to prevent chronic kidney disease in the community.
  • Medical experts provided free workshops on kidney health, safe medications, dialysis, and proper daily nutrition.
  • The local initiative directly supports the mayor’s long-term goal of making Chiang Rai a true “Wellness City.”

A professional medical team from Chiang Rai Prachanukroh Hospital led the educational health sessions. Dr. Parichat Khamlue opened the floor by discussing general kidney disease facts and related health complications. Next, Pharmacist Theeraporn Ekkabut warned attendees about how certain medicines and herbal products harm kidney function.

The community learning continued with practical care strategies for those already affected by illness. Registered Nurse Thanyalak Tharawijitkul shared important details about managing chronic kidney failure through proper dialysis. Additionally, Nutritionist Phimphan Wisutthikan explained how a balanced diet plays a huge role in supporting kidney health.

Interactive Health Booths and Daily Habits

Beyond just listening to medical lectures, attendees eagerly participated in hands-on health promotion booths. These interactive learning stations gave people highly practical health tips for their busy daily routines. Ultimately, the local goal is to help everyone apply these healthy habits in real life with complete confidence.

This entire health project strongly reflects the modern vision of Chiang Rai Mayor Wanchai Jongsuthanamanee. He is currently working very hard to transform the area into a leading Wellness City. Leaders truly believe that strong community health must start right at the basic family level.

When individual families stay healthy, the whole city naturally grows much stronger over time. Therefore, empowering local people with basic medical knowledge remains a vital step moving forward. This highly sustainable approach will surely improve the overall quality of life across all of Chiang Rai.

Trending News:

Traffic Alert: Chiang Rai Closes Highway 1232 for Flood Repairs

Chiang Rai Governor Launches 2026 Trade Push to Boost Local Businesses

 

 

Similar Posts

  • | | |

    Pattaya Deputy Mayor Opens Anti-Drug Training for Students on Koh Larn

    ByJustpaste.in

    Koh Larn, Pattaya, August 3rd, 2026 – Pattaya City Deputy Mayor Mr. Damrongkiat Pinijkarn led the opening ceremony of a school-based anti-drug immunity training program at Muang Pattaya School 10 (Ban Koh Larn). Senior executives from Pattaya City, D.A.R.E. police instructors from Muang Pattaya Police Station, teachers, and students attended the event in full force. […]

  • Thailand’s DDC Warns of Deadly Bacterial Infections During Rainy Season

    ByJustpaste.in

    CHIANG RAI – The Department of Disease Control recently issued an urgent public health warning regarding rising bacterial infections. Since January 2026, leptospirosis and melioidosis have killed over 100 people. This matters because vulnerable populations, particularly farmers, must adopt immediate protective measures to prevent further fatal outbreaks. Thailand’s Department of Disease Control (DDC) is sounding […]

  • | |

    Pattaya Officials Focus on E-Cigarette Laws and Youth Protection at National Health Conference

    ByJustpaste.in

    NONTHABURI, Thailand On August 7th, 2026, Mr. Poramese Ngamphichet, Mayor of Pattaya City, assigned Mr. Kiatisak Sriwongchai, Permanent Secretary of Pattaya City, to represent the municipality at the 24th National Health Academic Conference (CDoH). The conference, held under the theme “Sweet, Salty, Drunk, Smoke: Traps of Chronic Health-Damaging Products,” took place in the meeting room […]

  • Chiang Rai Advances “Holistic Care for the Elderly” Project for Better Quality of Life

    ByJustpaste.in

    CHAING RAI – The Chiang Rai Municipality is stepping up its efforts to improve the quality of life for senior citizens. Under the leadership of Mayor Wanchai Jongsuthanamanee, the city recently launched the “Holistic Care for the Elderly” project. This program is designed to help older adults build a stronger foundation for their physical, mental, […]

  • | |

    UK approves new drug aficamten for thousands of patients

    ByJustpaste.in

    A major breakthrough has been announced in the United Kingdom for thousands of people living with obstructive hypertrophic cardiomyopathy (HCM), a serious heart condition that can significantly affect quality of life. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have simultaneously approved and recommended a new treatment, Aficamten, marketed under the brand name MYQORZO. The decision marks an important milestone in the treatment of obstructive HCM and is expected to benefit around 6,600 patients in England. The coordinated approval process between MHRA and NICE enabled the medicine to become available more quickly than usual, ensuring that eligible patients gain faster access to this innovative therapy. Aficamten is a once-daily oral tablet designed to treat obstructive hypertrophic cardiomyopathy by reducing the excessive contraction of the heart muscle. In people with HCM, the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. This can lead to symptoms such as shortness of breath, chest pain, fatigue, dizziness, fainting, and irregular heart rhythms. By limiting the heart muscle’s excessive contraction, Aficamten improves blood flow from the heart, enhances overall cardiac function, and helps relieve these debilitating symptoms. Clinical trials have shown that Aficamten significantly improves patients’ ability to perform physical activities and reduces many of the common symptoms associated with the disease. Participants experienced better exercise capacity and reported less breathlessness, fatigue, chest discomfort, dizziness, and episodes of abnormal heartbeat. These findings indicate that the medication can substantially improve the quality of life for patients living with obstructive HCM. According to medical experts, the effectiveness of Aficamten is comparable to Mavacamten, another approved treatment for the condition. However, one potential advantage of Aficamten is that patients may require fewer echocardiograms, or heart ultrasound scans, during treatment. This could reduce the need for frequent hospital visits and ongoing monitoring, making treatment more convenient for both patients and healthcare providers. NICE stated that Aficamten was recommended after a comprehensive cost-effectiveness assessment showed that it represents good value for the National Health Service (NHS). The organization also highlighted that close collaboration with the MHRA helped accelerate the review and approval process without compromising safety or effectiveness. Helen Knight, Director of Medicines Evaluation at NICE, described the approval as an important advancement in the treatment of this complex heart disease. She said the new medicine offers fresh hope to patients and expands the range of available treatment options. Julian Beach, Executive Director at the MHRA, said the joint effort between the two organizations demonstrates the importance of collaboration in ensuring that safe and effective medicines reach patients as quickly as possible. The decision has also been welcomed by Cardiomyopathy UK. Chief Executive Katharine McIntosh said the availability of Aficamten would provide patients with more effective treatment options and help improve their overall quality of life. According to NHS England, the new medicine will be available to eligible patients within 30 days of NICE issuing its final guidance. The pharmaceutical company has also agreed to provide the medicine to the NHS at a discounted price, making the treatment more affordable and accessible. The approval represents a significant step forward in the management of obstructive hypertrophic cardiomyopathy and offers renewed hope for thousands of patients across England.

  • | |

    South Indian actress Shakeela undergoes neck surgery after excessive phone use

    ByJustpaste.in

      South Indian actress Shakeela has revealed that her excessive use of mobile phones left her with a serious neck problem that eventually required surgery costing around Rs300,000 Indian rupees. The 53-year-old actress shared her experience in a video posted on her YouTube channel and urged people, especially parents, to limit unnecessary mobile phone use. Shakeela, who has worked in Malayalam, Tamil, Kannada and Telugu films, said her habit of playing games and watching videos on her phone for several hours caused significant damage to her neck. She explained that she would often lie on her side in bed for long periods while using her phone. “I used to play games on my phone continuously for four hours while lying on my side in bed,” Shakeela said. She added that she would only get up occasionally to have tea or coffee before returning to her phone. After playing games, she would spend hours watching reels on YouTube and Instagram. According to the actress, maintaining an incorrect posture while using her phone, combined with prolonged screen time, affected important blood vessels in her neck and eventually led to serious health complications. She underwent surgery in Chennai and said that a titanium screw was also used during the procedure. After returning home, doctors advised Shakeela to wear a neck collar until she recovered. She said that following the surgery, she has needed assistance even with basic activities such as getting out of bed and eating. Shakeela stressed that mobile phones are useful devices when used responsibly, but excessive use can have serious consequences. She advised people not to spend unnecessary hours watching videos or playing games, even if the content is entertaining. She also issued a warning to parents, urging them to avoid giving mobile phones to children unnecessarily. According to her, children should use phones only for essential activities and educational or useful content rather than spending long periods watching short videos and playing games. The actress said that people could end up paying a heavy financial and physical price for excessive phone use, adding that her own experience had cost her around Rs300,000 and caused considerable pain and difficulty. Shakeela Begum was born in Chennai. Her mother, Chand Bee, was from Andhra Pradesh, while her father, Chand Basha, was from Tamil Nadu. She began her acting career with a Tamil film in 1995. However, she gained widespread recognition after appearing in the Malayalam film Kinnarathumbikal, released in 2000. Over the years, Shakeela became a well-known name in South Indian cinema, particularly for her work in Malayalam films. Her latest health experience has now prompted her to use her public platform to raise awareness about responsible mobile phone use and the potential health risks associated with prolonged screen time and poor posture.

Leave a Reply

Your email address will not be published. Required fields are marked *